Loading stock data…
$10.92+0.17 (+1.58%)
Oaktree Acquisition Corp.
Oaktree Acquisition Corp. III Life Sciences in the Financial Services sector is trading at $10.92 with a market capitalization of $265M. The stock is currently near its 52-week high of $10.92, remaining 2.2% above its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the safe zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$261,958↑ | -$456,538↓ | -$255,496↓ | -$225,579↑ | -$269,810 |
| Net Income | $1.60M↑ | $1.39M↓ | $1.79M↓ | $1.97M↑ | $1.87M |
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesse...